CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,673 | 23,019 | ||
| 2026-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise | +2,034 | 9,751 | ||
| 2026-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes | −706 | $32.02 | $23K | 9,045 |
| 2026-02-18 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award | −2,034 | 0 | ||
| 2026-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,355 | 107,301 | ||
| 2026-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −1,869 | $32.02 | $60K | 105,432 |
| 2026-02-18 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,355 | 0 | ||
| 2026-02-18 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +8,897 | 230,449 | ||
| 2026-02-18 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −3,796 | $32.02 | $122K | 226,653 |
| 2026-02-18 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −8,897 | 0 | ||
| 2026-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +8,897 | 84,535 | ||
| 2026-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,504 | $32.02 | $112K | 81,031 |
| 2026-02-18 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −8,897 | 0 | ||
| 2026-02-18 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +6,355 | 229,462 | ||
| 2026-02-18 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −2,126 | $32.02 | $68K | 227,336 |
| 2026-02-18 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −6,355 | 0 | ||
| 2026-02-05 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award | +149,580 | 1,439,970 | ||
| 2026-02-05 | POPS RICHARD F Director and CEO, Alkermes plc | Shares withheld for taxes | −62,230 | $33.55 | $2.1M | 1,377,740 |
| 2026-02-05 | Nichols Christian Todd SVP, Chief Commercial Officer | Grant or award | +21,127 | 107,335 | ||
| 2026-02-05 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −6,389 | $33.55 | $214K | 100,946 |
Page 9 of 41 · 804 trades